Thu, May 21, 2020

David Lebowitz Maintained (SNDX) at Hold with Increased Target to $22 on, May 21st, 2020

David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $10 to $22 on, May 21st, 2020.

David has made no other calls on SNDX in the last 4 months.



There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $25 on, Monday, May 11th, 2020
  • Peter Lawson of "Barclays" Initiated at Buy and Held Target at $15 on, Wednesday, March 4th, 2020